Jefferies & Co Upgrades ANSYS, Inc. (ANSS) to Buy
More News related to ANSS
- Ferrari Optimizes Thermal Comfort Using ANSYS
- SpaceClaim Announces New Engineering Software Release
- ANSYS Named to Software Top 100
- ANSYS Releases Engineering Knowledge Manager 2.0 for Simulation Data Capture, Reuse and Best Practices
- Shooting for the Moon: ANSYS Sponsors Astrobotic Technology
More News related to Upgrades
- Human Genome (HGSI) Raises Money As It Gears Up for Benlysta Approval
- Human Genome Sciences (HGSI) To Offer Up to 12.5M Shares
- ZymoGenetics (ZGEN) Higher Ahead of Presentation
- Somaxon Pharmaceuticals (SOMX) Surges Ahead of FDA Action Date
- BioMarin Pharmaceutical (BMRN) Announces FDA Grants Orphan Drug Designation for 3,4-DAP
Jefferies & Co upgrades ANSYS, Inc. (Nasdaq: ANSS) from Hold to Buy. Price target increased from $44 to $46.
To see more analyst ratings on ANSS Click Here.
ANSYS, Inc., together with its subsidiaries, engages in the development and marketing of engineering simulation software and services used by engineers and designers in aerospace, automotive, manufacturing, electronics, biomedical, and defense industries.
Related Categories
UpgradesStocks Mentioned
+0.28Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
